ranimustine has been researched along with nimustine in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (37.93) | 18.7374 |
| 1990's | 15 (51.72) | 18.2507 |
| 2000's | 2 (6.90) | 29.6817 |
| 2010's | 1 (3.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishiyama, Y; Kowada, M; Mineura, K | 2 |
| Oguro, M; Sakai, C; Takagi, T | 1 |
| Matsuura, Y; Oguro, M; Sakai, C; Takagi, T | 1 |
| Fujimoto, S; Nitta, K; Tokita, H | 1 |
| Kraemer, HP; Schönmayr, R; Tonn, JC | 1 |
| Shoin, K; Yamashima, T; Yamashita, J | 1 |
| Fushimi, S; Ikenaga, M; Ishizaki, K; Isowa, G; Kowada, M; Mineura, K | 1 |
| Kato, T; Ota, K | 2 |
| Fushimi, S; Itoh, Y; Kowada, M; Mineura, K | 1 |
| Fushimi, S; Ishino, Y; Kowada, M; Mineura, K; Sasajima, H; Sasaki, J | 1 |
| Harada, K; Kiya, K; Okamoto, H; Uozumi, T | 1 |
| Nomura, K; Shibui, S; Watanabe, T | 1 |
| Fujimoto, S; Ogawa, M | 2 |
| Wakui, A | 1 |
| Inoue, I; Kageyama, N; Kanzaki, M; Nagata, M; Wakabayashi, T; Yoshida, J | 1 |
| Oguro, M; Takenaga, K; Yanagawa, T | 1 |
| Kitamura, I; Kochi, M; Kuratsu, J; Seto, H; Takaki, S; Ushio, Y | 1 |
| Fujita, H; Hotta, T; Ikenaga, M; Ishizaki, K; Isowa, G; Kiya, K; Kurisu, K; Mikami, T; Saito, Y; Uozumi, T | 1 |
| Hotta, T; Ikenaga, M; Ishizaki, K; Isowa, G; Kiya, K; Kurisu, K; Mikami, T; Saito, Y; Uozumi, T | 1 |
| Kasai, M; Natsume, S; Satake, T; Shimokawa, T; Takeyama, H; Watanabe, E; Yamada, H | 1 |
| Fujiwara, S; Fukui, M; Inamura, T; Morioka, T; Nishio, S; Shono, T; Takeshita, I | 1 |
| Ishii, E; Kai, T; Matsuzaki, A; Ohnishi, Y; Ueda, K | 1 |
| Bandoh, S; Fujita, M; Funamoto, Y; Kuwabara, H; Nagai, M; Takahara, J; Tasaka, T; Yamaoka, G; Yamauchi, A | 1 |
| Hatano, N; Kajita, Y; Nagasaka, T; Thompson, T; Wakabayashi, T; Yoshida, J | 1 |
| Nagase, S; Ohkuma, S; Sato, S; Watanabe, S | 1 |
| Ikuta, S; Maruyama, T; Muragaki, Y; Nitta, M | 1 |
2 review(s) available for ranimustine and nimustine
| Article | Year |
|---|---|
[Cancer chemotherapy with special reference to pharmacokinetics of nitrosoureas].
Topics: Carmustine; Humans; Kinetics; Lomustine; Neoplasms; Nimustine; Nitrosourea Compounds; Semustine; Solubility; Streptozocin | 1982 |
Current status of nitrosoureas under development in Japan.
Topics: Animals; Antineoplastic Agents; Drug Evaluation; Humans; Japan; Neoplasms; Neoplasms, Experimental; Nimustine; Nitrosourea Compounds; Streptozocin | 1981 |
27 other study(ies) available for ranimustine and nimustine
| Article | Year |
|---|---|
Cross-resistance pattern in brain tumour cells resistant to antitumour chloroethylnitrosoureas.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Drug Resistance; Nimustine; Nitrosourea Compounds; Rats; Rats, Inbred F344; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1992 |
Development of resistance to antitumor chloroethylnitrosoureas in vitro in brain tumor cells.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Dose-Response Relationship, Drug; Drug Resistance; HeLa Cells; Humans; Nimustine; Nitrosourea Compounds; Rats; Rats, Inbred F344; Rats, Wistar; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1992 |
[BH-AC.nitrosourea-therapy for refractory or relapsed malignant lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nimustine; Nitrosourea Compounds; Recurrence | 1992 |
[In vitro effect of combined use of BH-AC and nitrosourea derivatives against adriamycin-resistant human leukemia cell line].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Leukemia; Nimustine; Nitrosourea Compounds; Tumor Cells, Cultured | 1991 |
[Antitumor spectra of ranimustine against various human tumors].
Topics: Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Neoplasms; Nimustine; Nitrosourea Compounds; Tumor Cells, Cultured; Urologic Neoplasms | 1991 |
Sensitivity of human malignant intracranial tumors against MCNU in vitro in comparison to ACNU and BCNU.
Topics: Aged; Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Carmustine; Drug Screening Assays, Antitumor; Female; Glioma; Humans; Male; Middle Aged; Nimustine; Nitrosourea Compounds; Tumor Cells, Cultured | 1990 |
Neurotoxicity of local administration of two nitrosoureas in malignant gliomas.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Dose-Response Relationship, Drug; Female; Glioma; Humans; Male; Middle Aged; Neurotoxins; Nimustine; Nitrosourea Compounds | 1990 |
Linkage between O6-methylguanine-DNA methyltransferase (O6-MT) activity and cellular resistance to antitumour nitrosoureas in cultured rat brain tumour cell strains.
Topics: Animals; Brain Neoplasms; Cell Line; Guanine; Humans; Methyltransferases; Nimustine; Nitrosourea Compounds; Rats | 1990 |
[Effects of derivatives of Ara-C, 5-fluorouracil and nitrosourea against intracerebral implanted L1210 leukemia].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Cytarabine; Fluorouracil; Leukemia L1210; Mice; Neoplasm Transplantation; Nimustine; Nitrosourea Compounds; Streptozocin; Tegafur; Uracil | 1987 |
DNA lability induced by nimustine and ramustine in rat glioma cells.
Topics: Animals; Antineoplastic Agents; Base Sequence; Brain Neoplasms; Cell Line; DNA Damage; DNA, Neoplasm; Dose-Response Relationship, Drug; Glioma; Nimustine; Nitrosourea Compounds; Rats; Tumor Cells, Cultured | 1988 |
[Analysis of DNA damage induced by nitrosourea derivatives in rat brain tumor cells using a sequencing procedure].
Topics: Animals; Antineoplastic Agents; Base Sequence; Brain Neoplasms; DNA Damage; DNA, Neoplasm; DNA, Satellite; Glioma; Nimustine; Nitrosourea Compounds; Rats | 1988 |
[Comparative studies on anti-tumor effects of nitrosoureas, ACNU and MCNU, on experimental brain tumors (author's transl)].
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Division; Glioma; Male; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Nimustine; Nitrosourea Compounds | 1981 |
[Application of flow cytometry to chemotherapy of malignant brain tumor].
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Survival; Cells, Cultured; DNA; Drug Evaluation, Preclinical; Drug Resistance; Flow Cytometry; Humans; Neoplasms, Experimental; Nimustine; Nitrosourea Compounds; Rats; Staining and Labeling | 1982 |
A new nitrosourea derivative TA-077, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea. I. Comparative study on antitumor activity.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Leukemia L1210; Leukemia P388; Lung Neoplasms; Male; Melanoma; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Nimustine; Nitrosourea Compounds; Streptozocin | 1982 |
[Comparative effect of administration schedules on the antitumor activities of 3 water-soluble nitrosoureas, ACNU, GANU and MCNU against L1210 leukemia].
Topics: Animals; Antineoplastic Agents; Drug Administration Schedule; Leukemia L1210; Mice; Nimustine; Nitrosourea Compounds; Solubility; Streptozocin | 1983 |
[MCNU effectiveness on brain tumor. Part I: Antitumor activity in vitro on human glioma and neuroblastoma cell lines].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Line; Cells, Cultured; DNA, Neoplasm; Flow Cytometry; Glioma; Humans; Mitosis; Neuroblastoma; Nimustine; Nitrosourea Compounds | 1984 |
[Antitumor activity of a new nitrosourea, MCNU, on a cellular morphological basis evaluated by a new in vitro antitumor sensitivity assay].
Topics: Animals; Antineoplastic Agents; Carmustine; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance; Humans; In Vitro Techniques; Leukemia L1210; Lomustine; Nimustine; Nitrosourea Compounds; Semustine; Tumor Stem Cell Assay | 1984 |
Neurotoxicity and pharmacokinetics of ventriculolumbar perfusion of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in dogs.
Topics: Animals; Antineoplastic Agents; Dogs; Drug Screening Assays, Antitumor; Nimustine; Nitrosourea Compounds | 1994 |
O6-alkylguanine-DNA alkyltransferase activity of human malignant glioma and its clinical implications.
Topics: Astrocytoma; Brain Neoplasms; Combined Modality Therapy; DNA Damage; DNA Repair; DNA, Neoplasm; Drug Resistance; Enzyme Induction; Glioblastoma; Glioma; Humans; Methyltransferases; Neoplasm Proteins; Neoplasm Recurrence, Local; Nimustine; Nitrosourea Compounds; O(6)-Methylguanine-DNA Methyltransferase; Tetrazolium Salts; Thiazoles | 1994 |
Interrelationship between O6-alkylguanine-DNA alkyltransferase activity and susceptibility to chloroethylnitrosoureas in several glioma cell lines.
Topics: Animals; Drug Resistance; Glioma; Humans; Interferon-beta; Methyltransferases; Nimustine; Nitrosourea Compounds; O(6)-Methylguanine-DNA Methyltransferase; Rats; Tumor Cells, Cultured | 1993 |
[Essential thrombocythemia clinical characteristics and course of 10 cases].
Topics: Adolescent; Adult; Aged; Bone Marrow; Female; Humans; Male; Middle Aged; Nimustine; Nitrosourea Compounds; Thrombocythemia, Essential | 1994 |
Chemotherapy for progressive pilocytic astrocytomas in the chiasmo-hypothalamic regions.
Topics: Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Etoposide; Female; Humans; Hypothalamus; Infant; Magnetic Resonance Imaging; Male; Nimustine; Nitrosourea Compounds; Optic Chiasm | 1995 |
Successful treatment with ranimustine and carboplatin for recurrent intraocular retinoblastoma with vitreous seeding.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Child, Preschool; Cyclophosphamide; Eye Neoplasms; Fatigue; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Seeding; Nimustine; Nitrosourea Compounds; Retinoblastoma; Vision, Ocular; Vitreous Body; Vomiting | 1996 |
Secondary myeloid/natural killer cell precursor acute leukemia following essential thrombocythemia.
Topics: Antigens, CD; Cell Transformation, Neoplastic; Humans; Immunophenotyping; Killer Cells, Natural; Leukemia, Myeloid; Male; Middle Aged; Nimustine; Nitrosourea Compounds; Thrombocythemia, Essential | 1999 |
Clinicopathological study of oligodendroglial tumors: the effectiveness of interferon beta, ACNU/MCNU, and radiation (IAR/IMR) for anaplastic tumors.
Topics: Adolescent; Adult; Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Interferon-beta; Male; Middle Aged; Neoplasm Recurrence, Local; Nimustine; Nitrosourea Compounds; Oligodendroglioma; Retrospective Studies; Survival Analysis | 2000 |
Chemotherapeutic choice of ranimustine or nimustine on the basis of regional polyamine levels in rat brain.
Topics: Animals; Antineoplastic Agents; Biogenic Polyamines; Brain Chemistry; Male; Nimustine; Nitrosourea Compounds; Rats; Rats, Sprague-Dawley | 2008 |
[Nimustine hydrochloride/ranimustine efficacy and safety in glioma].
Topics: Antineoplastic Agents; Brain Neoplasms; Glioma; Humans; Nimustine; Nitrosourea Compounds | 2016 |